ConductScience.org, home

Paper · 40910271

DBN1‑mediated upregulation of GAB2 facilitates the migration and invasion of T‑cell acute lymphoblastic leukemia cells.

Sun J and 10 others. Oncol Rep, 2025. Cited by 3 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. DBN1‑mediated upregulation of GAB2 facilitates the migration and invasion of T‑cell acute lymphoblastic leukemia cells. Papers, record 40910271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40910271

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
DBN1‑mediated upregulation of GAB2 facilitates the migration and invasion of T‑cell acute lymphoblastic leukemia cells.
PubMed
Journal
Oncol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-09-15
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun JJiaxing
2Huang XXiaoxing
3Zeng XXingruo
4Lei YYufei
5He HHengjing
6Wei ZZimeng
7Xiao DDi
8Zhang QQiuping
9Li XXinran
10Zhou FFuling

1 to 10 of 11Source PubMed

See all 11 authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptor Proteins, Signal TransducingMajor topic
Precursor T-Cell Lymphoblastic Leukemia-LymphomaMajor topic
Humans
Cell Movement
MicroRNAs
Cell Line, Tumor
Up-Regulation
Neoplasm Invasiveness
Male
Female
Gene Expression Regulation, Leukemic
Cell Proliferation
Adult
Signal Transduction

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,342,374Gab2-mediated signaling promotes melanoma metastasis.Am J Pathol2009https://conductscience.org/library/papers/19342374PubMed
228,830,639T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.Blood Rev2018https://conductscience.org/library/papers/28830639PubMed
328,804,122SHP2 is required for BCR-ABL1-induced hematologic neoplasia.Leukemia2018https://conductscience.org/library/papers/28804122PubMed
424,632,884Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.Blood Cancer J2014https://conductscience.org/library/papers/24632884PubMed
523,201,135The role of drebrin in glioma migration and invasion.Exp Cell Res2013https://conductscience.org/library/papers/23201135PubMed
628,634,044miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.Cancer Lett2017https://conductscience.org/library/papers/28634044PubMed
719,167,326MicroRNAs: target recognition and regulatory functions.Cell2009https://conductscience.org/library/papers/19167326PubMed
823,639,321Relapsed childhood acute lymphoblastic leukaemia.Lancet Oncol2013https://conductscience.org/library/papers/23639321PubMed
933,414,275Drebrin regulates cytoskeleton dynamics in migrating neurons through interaction with CXCR4.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33414275PubMed
1028,842,424Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.FASEB J2017https://conductscience.org/library/papers/28842424PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

None in this release.

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
DBN11,627PubTator's text mininghttps://conductscience.org/library/genes/1627NCBI Gene
GAB29,846PubTator's text mininghttps://conductscience.org/library/genes/9846NCBI Gene
MAPK15,594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
PIK3CB5,291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40910271

GET https://conductscience.org/api/papers/v1/40910271/references?page=2